Mnemonic to remember Receptor pharmacology (agonist, antagonist, partial agonist)

Receptor pharmacology questions love to test one thing: can you translate a drug’s “behavior at the receptor” into a graph, an effect, and a clinical consequence—fast. Here’s a quick, shareable mnemonic + visual that locks in agonist vs antagonist vs partial agonist in under a minute.

---

The 10-Second Core Idea (What they’re really asking)

On Step, receptor pharmacology usually boils down to two properties:

• Affinity = how well the drug binds the receptor
• Efficacy (intrinsic activity) = how well the drug activates the receptor once bound

Think: bind vs turn on.

---

The Mnemonic: “A.A.P.” = Activates / Abducts / Activates a bit

Picture a door with a light switch inside (the receptor).

A = Agonist = Activates

• Binds the receptor and turns it on fully
• One-liner: “Agonist: sits in the seat and floors the gas.”

A = Antagonist = Abducts (occupies)

• Binds the receptor but doesn’t turn it on
• One-liner: “Antagonist: sits in the seat and steals the keys.”

P = Partial agonist = Partially activates

• Binds the receptor and turns it on… but only halfway
• One-liner: “Partial agonist: presses the gas, but there’s a speed limiter.”

Memory hook:

• Agonist = All the action
• Antagonist = Absent action
• Partial agonist = Part action

---

Visual You Can Recall Under Pressure: “Gas Pedal Model”

High-yield one-liner:
A partial agonist can act like an antagonist when a full agonist is present, because it competes for binding (high affinity) but produces less effect (lower efficacy).

---

The Graph Trick (USMLE Favorite): Emax and EC50

What to remember

• $E_{\max}$ = maximum effect (depends on efficacy)
• $EC_{50}$ = concentration for 50% effect (depends on potency)

High-yield patterns

• Full agonist: highest $E_{\max}$
• Partial agonist: lower $E_{\max}$ than full agonist (no matter the dose)
• Neutral antagonist (competitive): no efficacy, but shifts agonist curve right (↑ $EC_{50}$) with same $E_{\max}$

Competitive antagonist hallmark

• Surmountable with more agonist
• Right shift: $\uparrow EC_{50}$ (↓ potency), $E_{\max}$ unchanged

Noncompetitive antagonist hallmark

• Not surmountable (can’t overcome with more agonist)
• $E_{\max}$ decreases

---

Super-Tested Clinical Examples (Tie it to real drugs)

Partial agonists that show up all the time

• Buprenorphine: partial $\mu$-opioid agonist
  • High-yield: less respiratory depression than full agonists, can precipitate withdrawal if given too soon after heroin/morphine (displaces full agonist, but gives less effect).
• Varenicline: partial nicotinic agonist
  • High-yield: reduces cravings by providing some receptor activation while blocking nicotine’s full effect.
• Aripiprazole: partial D2 agonist
  • High-yield concept: “dopamine stabilizer” (can lower D2 signaling when high, raise when low).

Classic antagonists

• Naloxone: competitive antagonist at opioid receptors
• Propranolol: competitive antagonist at $\beta$ receptors

---

Rapid-Fire USMLE “If you see this, think that”

• Drug binds but does nothing → antagonist (efficacy = 0)
• Drug produces effect but never reaches full max → partial agonist (lower $E_{\max}$)
• Adding antagonist shifts curve right, same max → competitive antagonist
• Adding antagonist lowers max → noncompetitive antagonist or irreversible binding
• Partial agonist given with full agonist decreases effect → partial agonist is acting as a functional antagonist

---

One Screenshot Summary (Shareable)

A.A.P. = Activates / Abducts / Activates a bit

• Agonist: high affinity + high efficacy → max effect
• Antagonist: high affinity + zero efficacy → blocks effect
• Partial agonist: high affinity + low efficacy → lower $E_{\max}$, can antagonize a full agonist